Cargando…

The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting

Bamlanivimab, a monoclonal antibody targeting the spike protein of severe acute respiratory syndrome coronavirus 2, is available for ambulatory treatment of coronavirus disease 2019 (COVID-19). This real-world study confirms the efficacy of bamlanivimab in reducing hospital admissions and emergency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corwin, Douglas S, Ender, Peter T, Sahu, Nitasa, Durgham, Ryan A, McGorry, Dennis M, Rahman, Awan, Stoltzfus, Jill, Jahre, Jeffrey A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272954/ https://www.ncbi.nlm.nih.gov/pubmed/34258324 http://dx.doi.org/10.1093/ofid/ofab305

Ejemplares similares

RETROSPECTIVE REVIEW OF MELATONIN IN PATIENTS WITH COVID-19
por: SAHU, NITASA, et al.
Publicado: (2021)

500. A Real-World Cohort Study of Bamlanivimab Versus Bamlanivimab-Etesevimab for Non-severe COVID-19
por: Monday, Lea, et al.
Publicado: (2021)

Real World Utilization of Bamlanivimab at a Rural Community Hospital
por: Leavitt, Rachael, et al.
Publicado: (2021)

Bamlanivimab infusion experience at one academic emergency department
por: Yoo, Michael J., et al.
Publicado: (2022)

Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study
por: Kumar, Rebecca N, et al.
Publicado: (2021)

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
por: O’Horo, John, et al.
Publicado: (2022)

Development of a Bamlanivimab Infusion Process in the Emergency Department for Outpatient COVID-19 Patients
por: Pham, Danny H., et al.
Publicado: (2021)

BAMLANIVIMAB-INDUCED GUILLAIN-BARRÉ SYNDROME
por: PALAGUACHI, GLADYS, et al.
Publicado: (2021)

Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region
por: Vena, Antonio, et al.
Publicado: (2021)

Health System Success in Delivering Bamlanivimab Within Post-acute and Long-Term Care Facilities
por: Walker, Victoria L., et al.
Publicado: (2022)

Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
por: Jan, Muhammad Y., et al.
Publicado: (2021)

Bamlanivimab: Guillain-Barre syndrome: case report
Publicado: (2021)

Bamlanivimab: New-onset seizures: case report
Publicado: (2022)

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
por: Dougan, Michael, et al.
Publicado: (2021)

Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
por: Destras, Grégory, et al.
Publicado: (2021)

Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
por: Zhang, Lin, et al.
Publicado: (2021)

506. Outpatient Bamlanivimab, Casirivimab and Imdevimab for COVID-19: Single Center Feasibility Analysis
por: Chundi, Vahini, et al.
Publicado: (2021)

Characteristics of Cannabis-Only and Other Drug Users Who Visit the Emergency Department
por: Woodruff, Susan I., et al.
Publicado: (2016)

542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19
por: Brock, Patricia, et al.
Publicado: (2021)

Contacting Patients After an Emergency Department Visit to Influence their Follow-Up Care Preferences
por: Bombard, Matthew C., et al.
Publicado: (2018)

Hyperbaric Oxygen Therapy Improving Penile Calciphylaxis
por: Lipinski, Matthew, et al.
Publicado: (2020)

Early Intervention in Psychosis: Obvious, Effective, Overdue
por: McGorry, Patrick D.
Publicado: (2015)

The reality of mental health care for young people, and the urgent need for solutions
por: McGorry, Patrick D
Publicado: (2021)

Adverse drug events leading to emergency department visits at an eye hospital: A brief report
por: Alizadeh, Safa, et al.
Publicado: (2017)

Opioid Overdose–Related Emergency Department Visits and Accidental Deaths during the COVID-19 Pandemic
por: Rodda, Luke N., et al.
Publicado: (2020)

Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection
por: Bavaro, DF, et al.
Publicado: (2022)

A comparison of ketamine versus etomidate for procedural sedation for the reduction of large joint dislocations
por: Salen, Philip, et al.
Publicado: (2016)

Drug-related emergency department visits in older patients: an applicability and reliability study of an existing assessment tool
por: Kempen, Thomas Gerardus Hendrik, et al.
Publicado: (2022)

Primary Sjögren's syndrome: Longitudinal real‐world, observational data on health‐related quality of life
por: Tarn, Jessica, et al.
Publicado: (2022)

Shock Index as a Marker for Mortality Rates in Those Admitted to the Medical Intensive Care Unit from the Emergency Department
por: Sahu, Nitasa, et al.
Publicado: (2020)

Sex- and Age-Related Impact of the COVID-19 Pandemic on Emergency Department Visits for Chest Pain in Curitiba, Brazil
por: Cunha, Gustavo Sarot Pereira da, et al.
Publicado: (2022)

First‐in‐Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID‐19
por: Chen, Peter, et al.
Publicado: (2021)

Bamlanivimab: Gene mutation in COVID-19 infection and off label use: case report
Publicado: (2022)

PK/PD modeling links accelerated resolution of COVID‐19‐related clinical symptoms to SARS‐CoV‐2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab together
por: Ernest, C. Steven, et al.
Publicado: (2022)

Real-world Accuracy of CGM in Inpatient Critical and Noncritical Care Settings at a Safety-Net Hospital
por: Finn, Erin, et al.
Publicado: (2023)

Early Treatment with Bamlanivimab Alone does not Prevent COVID-19 Hospitalization and Its Post-Acute Sequelae. A Real Experience in Umbria, Italy
por: Schiaroli, Elisabetta, et al.
Publicado: (2021)

Mental health-related visits in a pediatric emergency department during the COVID-19 pandemic
por: Fernandez, Arnaud, et al.
Publicado: (2021)

Experts use base rates in real-world sequential decisions
por: Link, Daniel, et al.
Publicado: (2021)

Impact of early versus late administration of bamlanivimab on readmissions in patients with high-risk COVID-19
por: Melton, James D., et al.
Publicado: (2021)

Efficacy of Bamlanivimab in Reducing Hospitalization and Mortality Rates in COVID-19 Patients in a Rural Community
por: Iqbal, Leena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bk810je8at4rmmsuo64uhhu0af